Personalised Medicine enabled by Intelligent SEnsing Systems (PI-SENS)

Programme

Cooperation Structures, COMET Projects Call 2022; funded by the FFG and the federal states of Lower Austria and Tyrol

Project coordination

Danube Private University, Univ. Prof. Dr. Christoph Kleber

Researchers involved at DPU

• Univ.-Prof. Dr. Winfried Neuhaus
• Univ.-Prof. Dr. Wolfgang Knoll
• Dr. Erich Kny
• Dr. Jakub Dostalek
• Univ.-Prof. Dr. med. dent. Constantin von See
• Dr. Katharina Schmidt
• Dr. Roger Hasler
• Dr. Nataliia Gnyliukh
• Dr. med. dent. Vera Zimprich
• Dipl. Ing. Dr. Dr. Rosmarie Bajlitz
• Abdellah Hambli
• Wiktor Luczak

Project partners

• BEGO Implant Systems GmbH & Co. KG
• Universität für Weiterbildung Krems
• NÖ Landesgesundheitsagentur
• AIT Austrian Institute of Technology GmbH
• DiagMetrics Inc.
• Medpol GmbH
• Schülke & Mayr Gesellschaft m.b.H.
• Cyprumed GmbH
• NOSI - Network for Olfactory System Intelligence GmbH
• 7S Health.Care GmbH
• Universität Linz
• Dr. Bohrer Lasertec GmbH
• Universität Ulm Institut für Pharmazeutische Biotechnologie
• LINXENS France
• biocrates life sciences gmbh
• HMNC Holding GmbH
• Hahn-Schickard-Gesellschaft für angewandte Forschung e.V.
• Universität Innsbruck
• Cells + Tissuebank Austria gemeinnützige GmbH
• Procomcure Biotech GmbH
• Sigmapharm Arzneimittel GmbH
• Villinger GmbH
• Universal Diagnostics SA
• Sulis Polymers B.V.

Abstract

Present health care systems need to be adapted because important ongoing and anticipated future social and technological trends will put increasing stress on the health systems in Austria as well as in the European Union and worldwide. The aging society, globalization as well as changes related to an urban lifestyle, individualism and living alone will cause additional pressures on health services. The healthcare system is challenged further by more and more patients with multiple problems. In the traditional approach the focus lies on the treatment of diseases and not so much on the prevention or avoidance of them. Even if prevention has come more and more into focus in recent years, the development of new and improved types of sensors for simple, preferably noninvasive and uncomplicated on-site diagnostic for prevention of diseases is required.

It is the purpose of the applied COMET Project application “Personalized Medicine Enabled by Intelligent Sensing Systems - PI-SENS” to contribute to the solutions for the rising national and international healthcare challenges. PI-SENS will provide essential know-how and technolgies for innovative solutions to establish a personalized health treatment and preventive care system.
The research activities of PI-SENS will thereby span the bridge from fundamental research to applied research and technology, prototyping development, and finally to innovative products by supporting its industrial cooperation partners. Due to the planned close cooperation with renowned national and international universities and research institutions, PI-SENS will contribute to premium education by offering young researchers a platform for conducting their bachelor, master and PhD theses, as well as attracting postdocs for an employment in the COMET project Initiative at the DPU. PI-SENS project work will contribute to the development of biosensors for monitoring of biomarkers in body fluids, e-Nose devices for smell pattern identification and development of organic field-effect transistors for endogenic and exogenic analysis, with the transition of the results into prototypes considering intelligent evaluation algorithms (AI). The operative work will be conducted in three Areas of Expertise (Biomedical Technologies, Analysis of Endogens and Analysis of Exogens) cooperating closely and thereby creating an added value compared to stand-alone projects. The consortium of PI-SENS features science at the highest level proven by a multitude of already conducted international and national funded projects in the field of sensing architecture development and an outstanding track record of the participating scientists.
The current necessity of funding a COMET project application like PI-SENS with the described research goals is demonstrated by the outstanding level of interest from participating pharmaceutical and medical-technical industrial companies, proven by an oversubscription of 74 % of the maximum possible company partner contributions allowed in COMET. The high proportion of international industrial partners shows that such a research COMET project Initiative is also urgently needed not only in a national but also in an international context. Hence the results of projects conducted in PI-SENS will contribute to increased added value of the participating companies by the development of innovative products, thereby providing improved health care for the entire population.

Read more about the project

Pi-Sens-Website